Neurology

FDA Turns Down Abuse-Deterrent Remoxy ER for Pain

The FDA has followed its Advisory Committee’s earlier recommendation and nixed approval of abuse-deterrent oxycodone extended-release capsules (Remoxy ER) for severe pain.
FDA Approvals

Source link

Related posts

Environment and Neurological Diseases: Growing Evidence for Direct Relationship

Newsemia

Author response: Circulating cortisol and cognitive and structural brain measures: The Framingham Heart Study

Newsemia

Study offers clues about how to prevent brain inflammation in Alzheimer's

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World